These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 17846326)
1. Protein precoating of elastomeric tissue-engineering scaffolds increased cellularity, enhanced extracellular matrix protein production, and differentially regulated the phenotypes of circulating endothelial progenitor cells. Sales VL; Engelmayr GC; Johnson JA; Gao J; Wang Y; Sacks MS; Mayer JE Circulation; 2007 Sep; 116(11 Suppl):I55-63. PubMed ID: 17846326 [TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-beta1 modulates extracellular matrix production, proliferation, and apoptosis of endothelial progenitor cells in tissue-engineering scaffolds. Sales VL; Engelmayr GC; Mettler BA; Johnson JA; Sacks MS; Mayer JE Circulation; 2006 Jul; 114(1 Suppl):I193-9. PubMed ID: 16820571 [TBL] [Abstract][Full Text] [Related]
3. Construction of tissue-engineered heart valves by using decellularized scaffolds and endothelial progenitor cells. Fang NT; Xie SZ; Wang SM; Gao HY; Wu CG; Pan LF Chin Med J (Engl); 2007 Apr; 120(8):696-702. PubMed ID: 17517187 [TBL] [Abstract][Full Text] [Related]
4. Endothelial progenitor cells as a sole source for ex vivo seeding of tissue-engineered heart valves. Sales VL; Mettler BA; Engelmayr GC; Aikawa E; Bischoff J; Martin DP; Exarhopoulos A; Moses MA; Schoen FJ; Sacks MS; Mayer JE Tissue Eng Part A; 2010 Jan; 16(1):257-67. PubMed ID: 19698056 [TBL] [Abstract][Full Text] [Related]
5. Valvular interstitial cell seeded poly(glycerol sebacate) scaffolds: toward a biomimetic in vitro model for heart valve tissue engineering. Masoumi N; Johnson KL; Howell MC; Engelmayr GC Acta Biomater; 2013 Apr; 9(4):5974-88. PubMed ID: 23295404 [TBL] [Abstract][Full Text] [Related]
6. Co-expression of elastin and collagen leads to highly compliant engineered blood vessels. Gao J; Crapo P; Nerem R; Wang Y J Biomed Mater Res A; 2008 Jun; 85(4):1120-8. PubMed ID: 18412137 [TBL] [Abstract][Full Text] [Related]
7. The in vitro development of autologous fibrin-based tissue-engineered heart valves through optimised dynamic conditioning. Flanagan TC; Cornelissen C; Koch S; Tschoeke B; Sachweh JS; Schmitz-Rode T; Jockenhoevel S Biomaterials; 2007 Aug; 28(23):3388-97. PubMed ID: 17467792 [TBL] [Abstract][Full Text] [Related]
8. The independent role of cyclic flexure in the early in vitro development of an engineered heart valve tissue. Engelmayr GC; Rabkin E; Sutherland FW; Schoen FJ; Mayer JE; Sacks MS Biomaterials; 2005 Jan; 26(2):175-87. PubMed ID: 15207464 [TBL] [Abstract][Full Text] [Related]
9. Growth factors upregulate deposition and remodeling of ECM by endothelial cells cultured for tissue-engineering applications. Divya P; Sreerekha PR; Krishnan LK Biomol Eng; 2007 Dec; 24(6):593-602. PubMed ID: 17869171 [TBL] [Abstract][Full Text] [Related]
11. Healing and remodeling of bioengineered pulmonary artery patches implanted in sheep. Mendelson K; Aikawa E; Mettler BA; Sales V; Martin D; Mayer JE; Schoen FJ Cardiovasc Pathol; 2007; 16(5):277-82. PubMed ID: 17868878 [TBL] [Abstract][Full Text] [Related]
12. Toward engineering a human neoendothelium with circulating progenitor cells. Allen JB; Khan S; Lapidos KA; Ameer GA Stem Cells; 2010 Feb; 28(2):318-28. PubMed ID: 20013827 [TBL] [Abstract][Full Text] [Related]
13. A biocompatible endothelial cell delivery system for in vitro tissue engineering. Lee EJ; Vunjak-Novakovic G; Wang Y; Niklason LE Cell Transplant; 2009; 18(7):731-43. PubMed ID: 19500475 [TBL] [Abstract][Full Text] [Related]
14. Use of human umbilical cord blood-derived progenitor cells for tissue-engineered heart valves. Sodian R; Schaefermeier P; Abegg-Zips S; Kuebler WM; Shakibaei M; Daebritz S; Ziegelmueller J; Schmitz C; Reichart B Ann Thorac Surg; 2010 Mar; 89(3):819-28. PubMed ID: 20172137 [TBL] [Abstract][Full Text] [Related]
16. Design and testing of a cyclic stretch and flexure bioreactor for evaluating engineered heart valve tissues based on poly(glycerol sebacate) scaffolds. Masoumi N; Howell MC; Johnson KL; Niesslein MJ; Gerber G; Engelmayr GC Proc Inst Mech Eng H; 2014 Jun; 228(6):576-586. PubMed ID: 24898445 [TBL] [Abstract][Full Text] [Related]
17. Artificial niche combining elastomeric substrate and platelets guides vascular differentiation of bone marrow mononuclear cells. Wu W; Allen R; Gao J; Wang Y Tissue Eng Part A; 2011 Aug; 17(15-16):1979-92. PubMed ID: 21449713 [TBL] [Abstract][Full Text] [Related]
18. Use of human aortic extracellular matrix as a scaffold for construction of a patient-specific tissue engineered vascular patch. Gao LP; Du MJ; Lv JJ; Schmull S; Huang RT; Li J Biomed Mater; 2017 Oct; 12(6):065006. PubMed ID: 28714856 [TBL] [Abstract][Full Text] [Related]
19. Developing a tissue engineered repair material for treatment of stress urinary incontinence and pelvic organ prolapse-which cell source? Roman S; Mangera A; Osman NI; Bullock AJ; Chapple CR; MacNeil S Neurourol Urodyn; 2014 Jun; 33(5):531-7. PubMed ID: 23868812 [TBL] [Abstract][Full Text] [Related]
20. Effect of passage number and matrix characteristics on differentiation of endothelial cells cultured for tissue engineering. Prasad Chennazhy K; Krishnan LK Biomaterials; 2005 Oct; 26(28):5658-67. PubMed ID: 15878371 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]